VCs still funding next-gen biofuel companies

Despite continued struggles for next-gen biofuel makers, VCs are still putting money into startups, particularly when it comes to follow-on rounds. EdeniQ announced that it has raised another round of more than $30 million from investors including Kleiner Perkins, Draper Fisher Jurvetson, and The Westly Group.

Amyris shores up company with $84M

Biochemical company Amyris announced on Monday that it has secured $84 million in funding to help it shore up its business and continue to try to scale up its technology. The company went public back in Fall 2010.

The state of biofuels and the public markets

Biofuel and biochemical companies continue to file to go public. But the reality is that the stocks of most of the publicly-traded biochemical and biofuel companies have suffered this year. Here’s the latest on the biofuel firms’ earnings from last week and stock prices.

Bill Joy aims for early failures and bigger impacts

When an investor or entrepreneur makes high-risk bets on early stage companies, failure is always part of the equation. For Kleiner Perkin’s Bill Joy he says more of the early-stage greentech startups he invests in with fail early, but can turn into something more meaningful.

Headwinds Too Strong for First Wind IPO

First Wind Holdings has canceled its IPO, joining the ranks of greentech hopefuls that have found the recent economic climate — or perhaps, their own financials — too unfavorable to risk the public markets.

Who Wins In Amyris’ IPO?

Amyris, which started trading on the NASDAQ today, has racked up millions of dollars from investors since its founding in 2003, including Kleiner Perkins, Khosla Ventures, and French oil giant Total. For some of those backers who took a chance early on, it’s a decent exit.

Amyris Stock Stays Steady on First Day of Trading

How’s next-gen biofuel maker Amyris faring on its first day of trading? Not bad. Not rocking, but pretty steady. The company started trading at $16.50, traded as high as $17.40 by mid-morning, but dropped back down around $16.50 by the late afternoon.

Amyris Prices IPO Below Range at $16

Amyris has priced shares for its IPO at $16, below its previously anticipated range or $18 to $20. At least 5.3 million of Amyris’ shares will start trading later today under the symbol AMRS. The IPO has raised $84.8 million.